As among all patients with NSCLC, GLUT1 expression was correlated with high FDG-PET SUVmax (6.8 ± 3.6 vs. 3.3 ± 2.5, p < 0.001), but GLUT3 expression showed no correlation with any other markers. The gene discussed is SLC2A1; the disease is non-small cell lung carcinoma.